Dr. Reddy's Laboratories Ltd.

DRREDDY

₹5942.85

-0.24% (-14.3)

Market Cap

₹99,134 Cr.

P/E

18.96

Dr. Reddy's Laboratories Ltd.
Overview
Financials
Benchmarking
Shareholding
Pharma

Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.
Overview
Financials
Benchmarking
Shareholding
Pharma

Financial
Business

Financial

	Dr. Reddy's Lab	Gland Pharma	Glenmark Pharma
Operational Metrics
API Sector
Global DMFs filed	1095.0 .	n/a	n/a
Pharmaceutical Sector
Number of ANDA's Filed in USA	339.0 .	346.0 .	13.0 .
Number of ANDA's Approved By USFDA	260.0 .	279.0 .	25.0 .
Domestic Sales Growth - YoY	4.9 %	n/a	9.8 %
R&D as a % of Total Sales	7.7 %	4.8 %	10.61 %
Financials
5 yr Average ROE	13.74 %	16.21 %	11.3 %
5yr average Equity Multiplier	1.45	1.1	1.97
5yr Average Asset Turnover Ratio	0.76	0.54	0.79
5yr Avg Net Profit Margin	12.57 %	26.8 %	7.09 %
Price to Book	3.89	3.49	3.1
P/E	18.96	44.05	0.0
5yr Avg Cash Conversion Cycle	68.59 Days	141.92 Days	-113.73 Days
Inventory Days	75.58 Days	117.9 Days	50.29 Days
Days Receivable	103.01 Days	97.99 Days	44.33 Days
Days Payable	102.58 Days	98.36 Days	209.82 Days
5yr Average Interest Coverage Ratio	30.9	245.99	4.6
5yr Avg ROCE	17.57 %	21.37 %	17.22 %
5yr Avg Operating Profit Margin	22.4 %	39.34 %	19.07 %
5 yr average Debt to Equity	0.16	0.0	0.62
5yr CAGR Net Profit	18.24 %	0.21 %	-20.31 %
5yr Average Return on Assets	9.53 %	14.66 %	5.67 %
Shareholdings
Promoter Holding	26.65 %	57.86 %	46.64 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-0.09 %	-0.39 %	0.01 %
Change in Mutual Fund Holding (3 Yrs)	-5.35 %	12.81 %	7.28 %

Business

	Dr. Reddy's Lab	Gland Pharma	Glenmark Pharma
Product Wise Break-Up	Product Wise Break-Up Formulations 84.26 Pharmaceutical 14.12 Proprietary 1.62 Injectables 0 Pharmaceuticals 0 Glenmark Pharma (Branded generics) 0 Glenmark generics 0	Product Wise Break-Up Proprietary 0 Pharmaceutical 0 Glenmark generics 0 Glenmark Pharma (Branded generics) 0 Pharmaceutical 100.0 Formulations 0 Injectables 0	Product Wise Break-Up Proprietary 0 Pharmaceutical 0 Formulations 39.54 Branded Generics 60.46 Pharmaceuticals 0 Formulations 0 Injectables 0
Location Wise Break-Up	Location Wise Break-Up USA 43.39 India 20.52 Russia 8.63 Canada, Australia & New Zealand 0 Australia 0 Canada 0 Europe 0 Rest of the World 0 Latin America 0 North America 0 Others 27.46	Location Wise Break-Up North America 0 Australia 0 India 4.92 Canada, Australia & New Zealand 2.47 Latin America 0 Rest of the World 0 Russia 0 USA 53.17 Canada 0 Europe 21.04 Others 18.4	Location Wise Break-Up North America 26.22 Australia 0 India 9.01 Canada, Australia & New Zealand 0 Latin America 0 Rest of the World 24.92 Russia 0 USA 0 Canada 0 Europe 21.85 Others 18.0
Operating Profit Break-Up	Operating Profit Break-Up Global Generics 92.58 Pharmaceutical Services and Active Ingredients 5.47 Proprietary Products 1.95	-	-
Therapeutic Area Break-Up	Therapeutic Area Break-Up Oncology 22.77 Central Nervous System (CNS) 13.05 Pain Management 11.03 Gastro Intestinal 10.96 Respiratory 7.99 Anti-Infective 7.98 Cardiac Science 7.57 Others 18.65	-	-
Asset Break-Up	Asset Break-Up India 84.66 Switzerland 4.52 USA 2.41 Rest of the World 0 Europe 0 Latin America 0 North America 0 Others 8.41	-	Asset Break-Up North America 43.68 India 49.72 Switzerland 0 Latin America 2.37 Rest of the World 1.7 USA 0 Europe 2.54

Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd.

SIGN UP FOR FREE